Decheng Capital LLC Top Holdings and 13F Report (2025) About Decheng Capital LLCInvestment ActivityDecheng Capital LLC has $395.97 million in total holdings as of June 30, 2025.Decheng Capital LLC owns shares of 25 different stocks, but just 5 companies or ETFs make up 80% of its holdings.Approximately 1.24% of the portfolio was purchased this quarter.About 29.16% of the portfolio was sold this quarter.This quarter, Decheng Capital LLC has purchased 27 new stocks and bought additional shares in 3 stocks.Decheng Capital LLC sold shares of 8 stocks and completely divested from 3 stocks this quarter.Largest Holdings CG ONCOLOGY INC $165,663,394AARDVARK THERAPEUTICS INC $52,961,882Nuvation Bio $50,611,155Upstream Bio Inc. $36,072,517NewAmsterdam Pharma $13,944,700 Largest New Holdings this Quarter 76200L309 - Rezolute $267,154 Holding Largest Purchases this Quarter Arcellx 497,609 shares (about $4.05M)MOONLAKE IMMUNOTHERAPEUTICS 10,000 shares (about $472K)Rezolute 59,900 shares (about $267.15K)Krystal Biotech 1,000 shares (about $137.46K) Largest Sales this Quarter Lyell Immunopharma 11,313,875 shares (about $100.01M)Arcus Biosciences 648,789 shares (about $3.29M)Legend Biotech 80,000 shares (about $2.84M)Crinetics Pharmaceuticals 34,958 shares (about $1.01M)BeyondSpring 351,170 shares (about $825.25K) Sector Allocation Over TimeMap of 500 Largest Holdings ofDecheng Capital LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorCG ONCOLOGY INC$165,663,3940.0%6,371,66941.8%COMAARDVARK THERAPEUTICS INC$52,961,8820.0%3,917,29913.4%COMNUVBNuvation Bio$50,611,1550.0%25,954,43912.8%MedicalUpstream Bio Inc.$36,072,5170.0%3,285,2939.1%COMNAMSNewAmsterdam Pharma$13,944,7000.0%770,0003.5%MedicalBYSIBeyondSpring$10,648,980$825,249 ▼-7.2%4,531,4812.7%MedicalMRUSMerus$9,946,5550.0%189,0982.5%MedicalKRYSKrystal Biotech$9,072,360$137,460 ▲1.5%66,0002.3%MedicalMOONLAKE IMMUNOTHERAPEUTICS$8,571,520$472,000 ▲5.8%181,6002.2%COMRVMDRevolution Medicines$8,314,5400.0%226,0002.1%MedicalACRSAclaris Therapeutics$5,739,2650.0%4,041,7361.4%MedicalLYELLyell Immunopharma$5,263,919$100,014,647 ▼-95.0%595,4661.3%MedicalACLXArcellx$4,457,537$4,050,537 ▲995.2%547,6091.1%MedicalCRNXCrinetics Pharmaceuticals$4,112,680$1,005,392 ▼-19.6%143,0001.0%MedicalAURAAura Biosciences$3,227,3740.0%515,5550.8%MedicalZNTLZentalis Pharmaceuticals$1,535,059$807,864 ▼-34.5%1,323,3270.4%MedicalEQEquillium$1,401,7920.0%4,447,3080.4%MedicalFDMT4D Molecular Therapeutics$888,582$356,179 ▼-28.6%239,5100.2%MedicalRCUSArcus Biosciences$811,200$3,289,360 ▼-80.2%160,0000.2%MedicalILMNIllumina$761,276$359,696 ▼-32.1%7,9790.2%MedicalLEGNLegend Biotech$709,800$2,839,200 ▼-80.0%20,0000.2%MedicalGRAIL INC$497,9510.0%9,6840.1%COMPYXSPyxis Oncology$359,4910.0%326,8100.1%MedicalRZLTRezolute$267,154$267,154 ▲New Holding59,9000.1%MedicalNuvation Bio Inc.$127,3470.0%646,0570.0%WARRANTSCYTKCytokinetics$0$4,019,000 ▼-100.0%00.0%MedicalBNTXBioNTech$0$1,821,200 ▼-100.0%00.0%MedicalVERAVera Therapeutics$0$107,970 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access